Heather McSharry - Aug 7, 2025 Form 4 Insider Report for Jazz Pharmaceuticals plc (JAZZ)

Role
Director
Signature
By: /s/Adam Guttmann, as attorney in fact For: Heather McSharry
Stock symbol
JAZZ
Transactions as of
Aug 7, 2025
Transactions value $
-$217,938
Form type
4
Date filed
8/11/2025, 05:40 PM
Previous filing
Aug 6, 2024
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
McSharry Heather Ann Director 5TH FL, WATERLOO EXCHANGE, WATERLOO RD, DUBLIN 4, IRELAND By: /s/Adam Guttmann, as attorney in fact For: Heather McSharry 2025-08-11 0001576068

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction JAZZ Ordinary Shares Award $0 +3.51K +18.55% $0.00 22.4K Aug 7, 2025 Direct F1
transaction JAZZ Ordinary Shares Tax liability -$218K -1.96K -8.74% $111.25 20.4K Aug 8, 2025 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These restricted stock units are granted pursuant to the Issuer's 2007 Amended and Restated Non-Employee Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on July 24, 2026.
F2 Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.